ARCHIVES

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | March 11, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011

Gori to Hopkins Part Time, Keeps DCCP Deputy Job

September 1, 1978

In Brief: Armitage Appointed to NCAB; UT Board Approves New Clinical Building for MDACC

May 19, 2000